Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
US5762922A · kind A · utility
20Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 1994 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Jul 1, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to therapeutic methods for treating diseases associated with tumor necrosis factor-alpha (TNF-.alpha.) induced cell toxicity and/or complement induced cell toxicity, improved methods for treating diseases whose therapy comprises the administration of at least one growth factor, and improved methods for preventing cell death associated with acute tissue injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.